Publicaciones científicas

/cun/investigacion/publicaciones-cientificas/areaMain/02
  • EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

    Gouya L (1), Ventura P (2), Balwani M (3), Bissell DM (4), Rees DC (5), Stölzel U (6), Phillips JD (7), Kauppinen R (8), Langendonk JG (9), Desnick RJ (3), Deybach JC (1), Bonkovsky HL (10), Parker C (7), Naik H (3), Badminton M (11), Stein PE (5), Minder E (12), Windyga J (13), Bruha R (14), Cappellini MD (15), Sardh E (16), Harper P (16), Sandberg S (17), Aarsand AK (17), Andersen J (17), Alegre F (18), Ivanova A (19), Talbi N (20), Chan A (21), Querbes W (21), Ko J (21), Penz C (21), Liu S (21), Lin T (21), Simon A (21), Anderson KE (22).

    (1) Centre de Référence Maladies Rares Porphyries, Colombes, France.
    (2) Università degli Studi di Modena e Reggio Emilia, Emilia-Romagna, Italy.
    (3) Icahn School of Medicine at Mount Sinai, New York, NY, USA.
    (4) University of California, San Francisco, CA, USA.
    (5) King's College Hospital, King's College London, London, UK.
    (6) Klinikum Chemnitz Porphyria Center, Chemnitz, Germany.
    (7) University of Utah, Salt Lake City, UT, USA.
    (8) University Hospital of Helsinki, Helsinki, Finland.
    (9) Porphyria Center, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
    (10) Section on Gastroenterology & Hepatology, Wake Forest University/NC Baptist Medical Center, Winston-Salem, NC, USA.
    (11) University Hospital of Wales, Cardiff, UK.
    (12) Stadtspital Triemli, Zentrallabor, Zurich, Switzerland.
    (13) Department of Hemostatic Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
    (14) 4th internal clinic, General University Hospital, Charles University, Prague, Czech republic.
    (15) University of Milan, Fondazione IRCCS, Ca Granda, Milan, Italy.
    (16) Porphyria Centre Sweden, Centre for Inherited Metabolic Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    (17) Norwegian Porphyria Centre, Haukeland University Hospital, Bergen, Norway.
    (18) Clinica Universidad de Navarra, Navarra, Spain.
    (19) St. Ivan Rilski U Hospital, Sofia, Bulgaria.
    (20) Laboratory of Excellence GR-Ex, University of Paris, Paris, France.
    (21) Alnylam Pharmaceuticals, Cambridge, MA, USA.
    (22) University of Texas Medical Branch, Galveston, TX, USA

    Hepatology 12 de SEPTIEMBRE de 2019

  • Lercanidipine-induced chylous ascites: Case report and literature review

    Basualdo JE (1), Rosado IA (1), Morales MI (2), Fernández-Ros N (1), Huerta A (1), Alegre F (1), Landecho MF (1), Lucena JF (1).

    (1) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.

    Journal of Clinical of Pharmacy Therapeuthics 02 de OCTUBRE de 2017

  • Comment on "Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit" by Benoît Dupont et al.

    Alegre F (1), Huerta A (2), Landecho MF (2), Lucena JF (2).
    (1) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. Electronic address: falegre@unav.es.
    (2) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. 

    Digestive and Liver Disease 01 de FEBRERO de 2016

  • Enterococcal bloodstream infection. Design and validation of a mortality prediction rule

    Pérez-García A (1), Landecho MF (2), Beunza JJ (3), Conde-Estévez D (4), Horcajada JP (5), Grau S (4), Gea A (6), Mauleón E (7), Sorli L (5), Gómez J (8), Terradas R (9), Lucena JF (2), Alegre F (2), Huerta A (2), Del Pozo JL (10).
    (1) Department of Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, Pamplona, Spain.
    (3) Interdusciplinar Education, Universidad Europea, Pamplona, Spain.
    (4) Service of Pharmacy, Hospital Universitari del Mar, Barcelona, Spain.
    (5) Service of Infectious diseases, Hospital Universitari del Mar, Institut Hospital del Mar d'Investigacions Médiques, CEXS-Universitat Pompeu Fabra, CIBERES, Barcelona, Spain.
    (6) Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain.
    (7) Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (8) Depatament of Microbiology, Laboratori de Referencia de Catalunya, Barcelona, Spain.
    (9) Service of Evaluation and Clinical Epidemiology, Hospital Universitari del Mar, Barcelona, Spain.
    (10) Division of Infectious diseases, Department Clinical Microbiology, Clínica Universidad de Navarra, Pamplona, Spain. 

    International Journal of Clinical Practice 01 de FEBRERO de 2016

  • Mortality Prediction in Patients Undergoing Non-Invasive Ventilation in Intermediate Care

    Martinez-Urbistondo D (1), Alegre F (1), Carmona-Torre F (1), Huerta A (1), Fernandez-Ros N (1), Landecho MF (2), García-Mouriz A (3), Núñez-Córdoba JM (4), García N (1), Quiroga J (5), Lucena JF (1).
    (1) Clínica Universidad de Navarra, Department of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Pamplona, Spain.
    (2) Clínica Universidad de Navarra, Department of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (3) Clínica Universidad de Navarra, Information Technology, Pamplona, Spain.
    (4) Clínica Universidad de Navarra, Division of Biostatistics, Research Support Service, Central Clinical Trials Unit, Pamplona, Spain; Department of Preventive Medicine and Public Health, Medical School, Universidad de Navarra, Pamplona, Spain; Epidemiology and Public Health Area, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (5) Clínica Universidad de Navarra, Department of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain. 

    PloS One 01 de OCTUBRE de 2015

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra